Mar 1, 2018
Dystonia refers to a complex spectrum of disturbances in movement, and the differential diagnosis is even more complicated. But Drs. Andres Deik and David Coughlin make it simple. In this week's episode of the BrainWaves podcast, we'll run through the basics of a dystonia differential and approach to managing patients with these complex symptoms.
Produced by James E. Siegler and David Coughlin. Music by Lee Rosevere, Rui, and the Freeharmonic Orchestra. BrainWaves' podcasts and online content are intended for medical education only and should not be used for clinical decision making.
1. Skogseid IM. Dystonia–new advances in classification, genetics, pathophysiology and treatment. Acta Neurologica Scandinavica. 2014 Apr 1;129(s198):13-9.
2. Albanese A, Bhatia K, Bressman SB, DeLong MR, Fahn S, Fung VS, Hallett M, Jankovic J, Jinnah HA, Klein C, Lang AE. Phenomenology and classification of dystonia: a consensus update. Movement Disorders. 2013 Jun 15;28(7):863-73.
3. Albanese A, Barnes MP, Bhatia KP, Fernandez‐Alvarez E, Filippini G, Gasser T, Krauss JK, Newton A, Rektor I, Savoiardo M, Valls‐Solè J. A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS‐ES task force. European journal of neurology. 2006 May 1;13(5):433-44.
Andres Deik has received consulting royalties from Adamas therapeutics, Teva pharmaceuticals, ITF Pharma, and Cynapsus Therapeutics. His research has been funded in part by Cynapsus therapeutics and The Dystonia Coalition. David Coughlin, like Jim Siegler, has no competing financial interests to disclose.